Xin Lang Cai Jing·2025-12-19 03:40Group 1 - Sino Medical's stock increased by 5.09%, reaching 18.39 CNY per share, with a trading volume of 169 million CNY and a turnover rate of 2.25%, resulting in a total market capitalization of 7.651 billion CNY [1] - Sino Medical, established on September 21, 2007, and listed on October 30, 2019, specializes in the research, production, and sales of high-end interventional medical devices, focusing on cardiovascular, cerebrovascular, and structural heart disease treatment areas [1] - The revenue composition of Sino Medical includes stents (59.76%), balloons (32.68%), and other products (7.56%) [1] Group 2 - The Guotai Haitong Quantitative Stock Mixed Fund A (016466) holds 444,300 shares of Sino Medical, representing 0.89% of the fund's net value, making it the top holding [2] - The fund has achieved a year-to-date return of 29.62%, ranking 2637 out of 8098 in its category, and a one-year return of 26.91%, ranking 2844 out of 8067 [2] - The fund was established on August 18, 2022, with a current size of 599 million CNY and has generated a cumulative return of 43.31% since inception [2]